Epidemiology of Melanoma and Nonmelanoma Skin Cancer—The Role of Sunlight

  • Ulrike Leiter
  • Claus Garbe
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 624)


Melanoma and nonmelanoma skin cancer (NMSC) are now the most common types of cancer in white populations. Both tumor entities show an increasing incidence rate worldwide but a stable or decreasing mortality rate.1,2 The rising incidence rates of NMSC are probably caused by a combination of increased sun exposure or exposure to ultraviolet (UV) light, increased outdoor activities, changes in clothing style, increased longevity, ozone depletion, genetics and in some cases, immune suppression. A dose-dependent increase in the risk of squamous cell carcinoma (SCC) of the skin was found associated with exposure to Psoralen and UVA irradiation. An intensive UV exposure in childhood and adolescence was causative for the development of basal cell carcinoma (BCC) whereas for the aetiology of SCC a chronic UV exposure in the earlier decades was accused.

Cutaneous malignant melanoma is the most rapidly increasing cancer in white populations. The frequency of its occurrence is closely associated with the constitutive colour of the skin and depends on the geographical zone. The highest incidence rates have been reported from Queensland, Australia with 56 new cases per year per 100,000 for men and 43 for women. Mortality rates of melanoma show a stabilisation in the USA, Australia and also in European countries. The tumor thickness is the most important prognostic factor in primary melanoma. There is an ongoing trend towards thin melanoma since the last two decades. Epidemiological studies have confirmed the hypothesis that the majority of all melanoma cases are caused, at least in part, by excessive exposure to sunlight. In contrast to squamous cell carcinoma, melanoma risk seems not to be associated with cumulative, but intermittent exposure to sunlight. Therefore campaigns for prevention and early detection are necessary.


Squamous Cell Carcinoma Skin Cancer Basal Cell Carcinoma Cutaneous Melanoma Tumor Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Holme SA, Malinovszky K, Roberts DL. Changing trends in nonmelanoma skin cancer in South Wales, 1988–98. Br J Dermatol 2000; 143:1224–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and nonmelanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146Suppl 61:1–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89:1269–78.PubMedCrossRefGoogle Scholar
  5. 5.
    Jemal A, Devesa SS, Hartge P et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93:678–83.PubMedCrossRefGoogle Scholar
  6. 6.
    Levi F, Te VC, Randimbison L et al. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res 2005; 15:73–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Mansson-Brahme E, Johansson H, Larsson O et al. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976–1994. Acta Oncol 2002; 41:138–46.PubMedCrossRefGoogle Scholar
  8. 8.
    Ocana-Riola R, Martinez-Garcia C, Serrano S et al. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985–1992. Eur J Epidemiol 2001; 17:169–74.PubMedCrossRefGoogle Scholar
  9. 9.
    Stang A, Jockel KH. Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968–99. Br J Dermatol 2004; 150:517–22.PubMedCrossRefGoogle Scholar
  10. 10.
    Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol 1994; 102:6S–9S.PubMedCrossRefGoogle Scholar
  11. 11.
    Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definitions and classification. J Invest Dermatol 1994; 102:4S–5S.PubMedCrossRefGoogle Scholar
  12. 12.
    Armstrong BK, Kricker A, English DR. Sun exposure and skin cancer. Australas J Dermatol 1997; 38Suppl 1:S1–S6.PubMedGoogle Scholar
  13. 13.
    Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63:8–18.PubMedCrossRefGoogle Scholar
  14. 14.
    MacLennan R, Green AC, McLeod GR et al. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84:1427–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection and treatment in the 21st century. CA Cancer J Clin 2000; 50:215–36.PubMedCrossRefGoogle Scholar
  16. 16.
    Haberland J, Bertz J, Gorsch B et al. Krebsinzidenzschätzungen fur Deutschland mittels log-linearer Modelle. Gesundheitswesen 2001; 63:556–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Lasithiotakis KG, Leiter U, Gorkievicz R et al. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 2006; 107:1331–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Diffey BL. The future incidence of cutaneous melanoma within the UK. Br J Dermatol 2004; 151:868–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Stang A, Stang K, Stegmaier C et al. Skin melanoma in Saarland: incidence, survival and mortality 1970–1996. Eur J Cancer Prev 2001; 10:407–15.PubMedCrossRefGoogle Scholar
  20. 20.
    Bosetti C, La Vecchia C, Naldi L et al. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 2004; 14:301–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Stracci F, Minelli L, D’Alo D et al. Incidence, mortality and survival trends of cutaneous melanoma in Umbria, Italy. 1978–82 and 1994–98. Tumori 2005; 91:6–8.PubMedGoogle Scholar
  22. 22.
    Gray DT, Suman VJ, Su WP et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997; 133:735–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999; 135:781–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Iversen T, Tretli S. Trends for invasive squamous cell neoplasia of the skin in Norway. Br J Cancer 1999; 81:528–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Karagas MR, Greenberg ER, Spencer SK et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999; 81:555–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Staples M, Marks R, Giles G. Trends in the incidence of nonmelanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78:144–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Weinstock MA. Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am 1998; 12:681–98.PubMedCrossRefGoogle Scholar
  28. 28.
    Elder DE. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 1995; 75:245–56.PubMedCrossRefGoogle Scholar
  29. 29.
    Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 1999; 135:843–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587–93.PubMedCrossRefGoogle Scholar
  31. 31.
    Green A, MacLennan R, Youl P et al. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53:232–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. Int J Dermatol 2002; 41:652–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Krebsregister Schleswig-Holstein Instituts für Krebsepidemiologie. Krebs in Schleswig-Holstein 2004. Ref Type: Generic.Google Scholar
  34. 34.
    The Danish National Boardof Health. Cancer Incidence in Denmark 1997. 2001. Ref Type: Generic.Google Scholar
  35. 35.
    Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977–1978 and 1998–1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003; 12:1105–8.PubMedGoogle Scholar
  36. 36.
    Katalinic A. [Population-based cancer registration in Germany. Essentials and perspectives]. Bundesgesundheitsblatt. Gesundheitsforschung Gesundheitsschutz 2004; 47:422–8.CrossRefGoogle Scholar
  37. 37.
    Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988–2000): the Rhode Island follow-back study. Arch Dermatol 2004; 140:837–42.PubMedCrossRefGoogle Scholar
  38. 38.
    Schuz J, Schon D, Batzler W et al. Cancer registration in Germany: current status, perspectives and trends in cancer incidence 1973–93. J Epidemiol Biostat 2000; 5:99–107.PubMedGoogle Scholar
  39. 39.
    Stang A, Stegmaier C, Jockel KH. Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995–1999. Br J Cancer 2003; 89:1205–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Vinceti M, Bergomi M, Borciani N et al. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1999; 9:97–103.PubMedCrossRefGoogle Scholar
  41. 41.
    Lehnert M, Eberle A, Hentschel S et al. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany-incidence, clinical parameters, variations in recording]. Gesundheitswesen 2005; 67:729–35.PubMedCrossRefGoogle Scholar
  42. 42.
    Gallagher RP, Hill GB, Bajdik CD et al. Sunlight exposure, pigmentation factors and risk of nonmela-nocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131:164–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Stern RS. Risks of cancer associated with long-term exposure to PUVA in humans: current status-1991. Blood Cells 1992; 18:91–7.PubMedGoogle Scholar
  44. 44.
    Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14:562–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Ulrich C, Schmook T, Nindl I et al. Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding. Br J Dermatol 2003; 149Suppl 66:40–2.PubMedCrossRefGoogle Scholar
  46. 46.
    Ulrich C, Schmook T, Sachse MM et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622–7.PubMedCrossRefGoogle Scholar
  47. 47.
    English DR, Armstrong BK, Kricker A et al. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 1998; 77:347–53.PubMedCrossRefGoogle Scholar
  48. 48.
    Kricker A, Armstrong BK, English DR. Sun exposure and nonmelanocytic skin cancer. Cancer Causes Control 1994; 5:367–92.PubMedCrossRefGoogle Scholar
  49. 49.
    Kricker A, Armstrong BK, McMichael AJ. Skin cancer and ultraviolet. Nature 1994; 368:594.PubMedCrossRefGoogle Scholar
  50. 50.
    Kricker A, Armstrong BK, English DR et al. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 1995; 60:489–94.PubMedCrossRefGoogle Scholar
  51. 51.
    de Villiers EM. Human papillomavirus infections in skin cancers. Biomed Pharmacother 1998; 52:26–33.PubMedCrossRefGoogle Scholar
  52. 52.
    Green A, Marks R. Squamous cell carcinoma of the skin (nonmetastatic). Clin Evid 2005; 2086–90.Google Scholar
  53. 53.
    Ziegler A, Leffell DJ, Kunala S et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Nad Acad Sci USA 1993; 90:4216–20.CrossRefGoogle Scholar
  54. 54.
    Zhang H, Ping XL, Lee PK et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 2001; 158:381–5.PubMedGoogle Scholar
  55. 55.
    Athar M, Tang X, Lee JL et al. Hedgehog signalling in skin development and cancer. Exp Dermatol 2006; 15:667–77.PubMedCrossRefGoogle Scholar
  56. 56.
    Daya-Grosjean L, Sarasin A. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat Res 2000; 450:193–9.PubMedGoogle Scholar
  57. 57.
    Levanat S, Mubrin MK, Crnic I et al. Variable expression of Gorlin syndrome may reflect complexity of the signalling pathway. Pflugers Arch 2000; 439:R31–R33.PubMedCrossRefGoogle Scholar
  58. 58.
    Situm M, Levanat S, Crnic I et al. Involvement of patched (PTCH) gene in Gorlin syndrome and related disorders: three family cases. Croat Med J 1999; 40:533–8.PubMedGoogle Scholar
  59. 59.
    Ping XL, Ratner D, Zhang H et al. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol 2001; 116:614–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Ling G, Ahmadian A, Persson A et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001; 20:7770–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354:723–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969–93. Cancer Causes Control 1999; 10:407–16.PubMedCrossRefGoogle Scholar
  63. 63.
    de Vries E, Bray FI, Coebergh JW et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 107:119–26.PubMedCrossRefGoogle Scholar
  64. 64.
    Geller AC, Miller DR, Annas GD et al. Melanoma incidence and mortality among US whites, 1969–1999. JAMA 2002; 288:1719–20.PubMedCrossRefGoogle Scholar
  65. 65.
    Dennis LK. Melanoma incidence by body site: effects of birth-cohort adjustment. Arch Dermatol 1999; 135:1553–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Hall HI, Miller DR, Rogers JD et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999; 40:35–42.PubMedCrossRefGoogle Scholar
  67. 67.
    Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996. Int J Cancer 2001; 92:457–62.PubMedCrossRefGoogle Scholar
  68. 68.
    Anonymus. Stat bite: Incidence of and mortality from melanoma of the skin, 1975–2000. J Natl Cancer Inst 2003; 95:933.Google Scholar
  69. 69.
    Jones WO, Harman CR, Ng AK et al. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 1999; 23:732–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000; 25:459–63.PubMedCrossRefGoogle Scholar
  71. 71.
    Osterlind A, Hou-Jensen K, Moller JO. Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types and comparison with nonmelanoma skin cancer. Br J Cancer 1988; 58:385–91.PubMedGoogle Scholar
  72. 72.
    Balzi D, Carli P, Giannotti B et al. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev 2003; 12:43–8.PubMedCrossRefGoogle Scholar
  73. 73.
    de Vries E, Bray FI, Eggermont AM et al. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev 2004; 13:387–95.PubMedCrossRefGoogle Scholar
  74. 74.
    Stang A, Jockel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 2003; 13:436–42.PubMedCrossRefGoogle Scholar
  75. 75.
    de Vries E, Schouten LJ, Visser O et al. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003;39:1439–46.PubMedCrossRefGoogle Scholar
  76. 76.
    MacKie RM, Bray CA, Hole DJ et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360:587–91.PubMedCrossRefGoogle Scholar
  77. 77.
    Berwick M, Armstrong BK, Ben Porat L et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97:195–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Berwick M, Halpern A. Melanoma epidemiology. Curr Opin Oncol 1997; 9:178–82.PubMedCrossRefGoogle Scholar
  79. 79.
    Buettner PG, Leiter U, Eigentler TK et al. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005; 103:616–24.PubMedCrossRefGoogle Scholar
  80. 80.
    Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res 1992;Suppl 2:285–94.PubMedGoogle Scholar
  81. 81.
    Garbe C, Weiss J, Kruger S et al. The German melanoma registry and environmental risk factors implied. Recent Results Cancer Res 1993; 128:69–89.PubMedGoogle Scholar
  82. 82.
    Garbe C, Buttner P, Bertz J et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 75:2492–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res 2002; 160:113–21.PubMedGoogle Scholar
  84. 84.
    Garbe C, Wiebelt H, Orfanos CE. Change of epidemiological characteristics of malignant melanoma during the years 1962–1972 and 1983–1986 in the Federal Republic of Germany. Dermatologica 1989; 178:131–5.PubMedCrossRefGoogle Scholar
  85. 85.
    Carli P, Borgognoni L, Biggeri A et al. Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study. Melanoma Res 1994; 4:385–90.PubMedCrossRefGoogle Scholar
  86. 86.
    Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5,702 patients with melanoma. Br J Dermatol 2006; 155:771–7.PubMedCrossRefGoogle Scholar
  87. 87.
    Whiteman DC, Stickley M, Watt P et al. Anatomic site, sun exposure and risk of cutaneous melanoma. J Clin Oncol 2006; 24:3172–7.PubMedCrossRefGoogle Scholar
  88. 88.
    Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 2003;22:3099–112.PubMedCrossRefGoogle Scholar
  89. 89.
    Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41:45–60.PubMedCrossRefGoogle Scholar
  90. 90.
    Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73:198–203.PubMedCrossRefGoogle Scholar
  91. 91.
    Garbe C, Buttner P, Weiss J et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102:700–5.PubMedCrossRefGoogle Scholar
  92. 92.
    Wiecker TS, Luther H, Buettner P et al. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 2003; 97:628–38.PubMedCrossRefGoogle Scholar
  93. 93.
    Bauer J, Buttner P, Wiecker TS et al. Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. Int J Cancer 2005.Google Scholar
  94. 94.
    Bauer J, Buttner P, Wiecker TS et al. Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care. Am J Epidemiol 2005; 161:620–7.PubMedCrossRefGoogle Scholar
  95. 95.
    De Fabo EC, Noonan FP, Fears T et al. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 2004; 64:6372–6.PubMedCrossRefGoogle Scholar
  96. 96.
    Wang SQ, Setlow R, Berwick M et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44:837–46.PubMedCrossRefGoogle Scholar
  97. 97.
    Thomas NE, Berwick M, Cordeiro-Stone M. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation? J. Invest Dermatol 2006; 126:1693–6.CrossRefGoogle Scholar
  98. 98.
    Dong J, Phelps RG, Qiao R et al. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 2003; 63:3883–5.PubMedGoogle Scholar
  99. 99.
    Kumar R, Angelini S, Snellman E et al. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 2004; 122:342–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Pollock PM, Harper UL, Hansen KS et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33:19–20.PubMedCrossRefGoogle Scholar
  101. 101.
    Yazdi AS, Palmedo G, Flaig MJ et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 2003; 121:1160–2.PubMedCrossRefGoogle Scholar
  102. 102.
    Battistutta D, Palmer J, Walters M et al. Incidence of familial melanoma and MLM2 gene. Lancet 1994; 344:1607–8.PubMedCrossRefGoogle Scholar
  103. 103.
    Monzon J, Liu L, Brill H et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med 1998; 338:879–87.PubMedCrossRefGoogle Scholar
  104. 104.
    Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95:1878–90.PubMedGoogle Scholar
  105. 105.
    Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51–65.PubMedCrossRefGoogle Scholar
  106. 106.
    Sauter ER, Yeo UC, von Stemm A et al. Cyclin Dl is a candidate oncogene in cutaneous melanoma. Cancer Res 2002; 62:3200–6.PubMedGoogle Scholar
  107. 107.
    Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. Cancer Surv 1996; 26:133–53.PubMedGoogle Scholar
  108. 108.
    MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer 1998; 34Suppl 3:S3–S6.PubMedCrossRefGoogle Scholar
  109. 109.
    Autier P, Dore JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int J Cancer 1998; 77:533–7.PubMedCrossRefGoogle Scholar
  110. 110.
    Eide MJ, Weinstock MA. Association of UV index, latitude and melanoma incidence in nonwhite populations—US Surveillance, Epidemiology and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005; 141:477–81.PubMedCrossRefGoogle Scholar
  111. 111.
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827–41.PubMedCrossRefGoogle Scholar
  112. 112.
    Hu S, Ma F, Collado-Mesa F, et al. UV radiation, latitude and melanoma in US Hispanics and blacks. Arch. Dermatol 2004; 140:819–24.PubMedCrossRefGoogle Scholar
  113. 113.
    Holman CD, Armstrong BK, Heenan PJ. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71:651–6.PubMedGoogle Scholar
  114. 114.
    Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12:69–82.PubMedCrossRefGoogle Scholar
  115. 115.
    Gilchrest BA, Eller MS, Geller AC et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340:1341–8.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2008

Authors and Affiliations

  • Ulrike Leiter
    • 1
  • Claus Garbe
    • 2
  1. 1.Division of Dermatooncology Department of DermatologyUniversity Medical Center Eberhard Karls-University of TuebingenTuebingenGermany
  2. 2.Division of Dermatoloncology, Department of Dermatology, University Medical CenterUniversity of TuebingenTuebingenGermany

Personalised recommendations